Introduction
Inflammatory bowel disease — Crohn's disease and ulcerative colitis — causes chronic inflammation of the digestive tract, and it's increasingly being diagnosed in children and adolescents, not just adults. Pediatric IBD isn't simply a smaller version of adult IBD: it often presents differently, tends to involve more extensive disease at diagnosis, and carries a consequence adult IBD doesn't — the potential to affect a child's growth and pubertal development if not caught and treated promptly. At KAGE, pediatric IBD care is built around that distinction, with growth and development treated as a core treatment goal, not a side effect to monitor separately.
How common is pediatric IBD, and is it really rising in India
Yes — and the data is fairly striking. A tertiary care center in Northern India documented a 2.75-fold rise in pediatric IBD cases between 2010 and 2020, consistent with the broader pattern of IBD rising rapidly across South Asia after historically being considered uncommon in the region. Globally, roughly a quarter of all IBD is diagnosed before age 18, and pediatric-onset incidence has tripled over the past two decades. In Indian pediatric data specifically, ulcerative colitis is more commonly diagnosed than Crohn's disease, with extensive colitis (affecting most or all of the colon) and ileocolonic Crohn's disease being the most common patterns seen.
Why pediatric IBD often looks different from adult IBD
The most important distinction for parents to understand is that pediatric IBD doesn't always announce itself with clear digestive symptoms first. Growth faltering — falling off a child's expected growth curve — and delayed puberty can be the earliest, or even the only, signs for some time before diarrhea, abdominal pain, or rectal bleeding become obvious. Because of this, and because early symptoms can be subtle or intermittent, pediatric IBD is also frequently diagnosed with more extensive disease already present at diagnosis compared to adults. Treatment goals reflect this too: pediatric IBD management isn't just about controlling symptoms, but specifically about protecting normal growth and pubertal development, which is why nutritional therapy plays a larger, more central role in children than it typically does in adult IBD care.
Pediatric IBD and intestinal TB: the same important distinction as in adults
As with adult IBD (see the Diarrhoea page for the full picture), Crohn's disease in children can be clinically and even endoscopically difficult to distinguish from intestinal tuberculosis, which remains far more relevant in the Indian context than in Western pediatric IBD literature. In Indian data, a meaningful proportion of children with suspected Crohn's disease receive a trial of anti-tuberculosis treatment before the diagnosis is fully confirmed — a reasonable and often necessary step given the overlap, but one that underscores why thorough, patient evaluation matters more here than following a single diagnostic shortcut.
Symptoms of pediatric IBD
- Growth faltering or unexplained weight loss — sometimes the earliest sign, and easy to miss without tracking growth over time
- Delayed puberty
- Chronic or recurrent diarrhea
- Abdominal pain
- Rectal bleeding
- Unexplained fatigue
- Fever without an obvious cause
- Joint pain, in some cases — IBD can involve symptoms outside the digestive tract
Why diagnostic delay matters so much in children specifically
Delayed diagnosis in pediatric IBD isn't just a matter of prolonged discomfort — research has consistently linked it to worse growth outcomes that can persist well beyond the point of diagnosis. One study found children with delayed diagnosis had nearly six times the risk of growth retardation at diagnosis compared to those diagnosed promptly, and that elevated risk was still measurable more than a year later. This is exactly why persistent, unexplained growth concerns in a child — even without obvious digestive symptoms — deserve proper gastroenterology evaluation rather than being attributed to ‘being a slow grower’ without investigation.
How pediatric IBD is diagnosed
- Blood tests — inflammatory markers and screening for anemia or nutritional deficiencies
- Stool tests — including fecal calprotectin, a useful marker of intestinal inflammation
- Upper GI endoscopy and colonoscopy with biopsy — the definitive way to confirm IBD and distinguish it from other causes, including intestinal TB
- Imaging (MRI or CT enterography) — to assess the small intestine, particularly relevant for suspected Crohn's disease
- Growth chart review — as much a diagnostic tool here as any single lab test
Pediatric IBD treatment: staged, with growth as a core goal
- Nutritional therapy — in some cases, particularly Crohn's disease, exclusive or partial nutritional therapy can induce remission while directly supporting growth, and is used more prominently in children than in adult IBD care
- Aminosalicylates — for milder ulcerative colitis
- Immunomodulators and biologic therapy — for more significant or treatment-refractory disease, following a step-up approach based on severity
- Corticosteroids — generally used briefly, given their own effects on growth with prolonged use
- Regular growth and pubertal monitoring throughout treatment, not just symptom tracking
- Surgery, in select cases, for complications or disease not responding to medical therapy
Living with pediatric IBD
Pediatric IBD is a chronic condition managed over years, not resolved with a single course of treatment. Ongoing growth and pubertal monitoring remains part of care even once symptoms are well controlled. The psychosocial side matters too — school attendance, participation in normal childhood activities, and a child's own understanding of their condition as they get older are all part of comprehensive care. As adolescents approach adulthood, planning a structured transition to adult IBD care is an important, deliberate part of the process, not something left until the last moment.
How pediatric IBD is managed here
IBD that presents in childhood tends to be more extensive and more aggressive than adult-onset disease, and growth failure is often the presenting sign rather than diarrhoea. Our pediatric gastroenterologists settle intestinal TB vs. Crohn's disease before starting immunosuppression, as in adults, and work with the IBD Clinic so that care transitions at eighteen rather than restarting. This sits within our wider pediatric gastroenterology service. To have your child assessed, book a consultation.
Frequently asked questions
Pediatric IBD often presents with more extensive disease at diagnosis, can show up first as growth or pubertal delay rather than classic digestive symptoms, and treatment specifically prioritizes protecting normal growth and development alongside controlling the disease itself.
It's a genuine and important possibility to rule out — the two can look very similar, and a trial of anti-TB treatment is often part of a thorough evaluation in Indian children before confirming an IBD diagnosis.
Consultation and standard diagnostic evaluation are generally covered under most health insurance plans; coverage for ongoing biologic therapy depends on your specific policy. Our team can help clarify coverage during consultation.
Prompt treatment gives the best chance of normal growth going forward, and many children do catch up meaningfully, though outcomes depend on how much delay occurred before diagnosis and treatment began.
Ulcerative colitis is more commonly diagnosed than Crohn's disease in Indian pediatric IBD data, often presenting as extensive colitis affecting most or all of the colon.
For most children, IBD is a chronic condition requiring ongoing management, though the specific treatment — including nutritional therapy in some cases — is tailored to disease type and severity, not a one-size-fits-all medication plan.
Genetic predisposition is a recognized factor, particularly relevant in South Asian populations, so a family history of IBD is a meaningful part of your child's evaluation.
Most children are managed successfully with medical and nutritional therapy. Surgery is reserved for specific complications or disease that doesn't respond adequately to medical treatment.
This is planned deliberately as adolescence progresses, rather than left until a sudden switch — your care team will discuss timing and the transition process well in advance.
Yes — very early onset IBD, diagnosed before age 6, is a recognized and distinct category that sometimes has an underlying genetic cause, and is evaluated with that possibility specifically in mind.
Book a consultation at KAGE
Speak to a KAGE gastroenterologist about your symptoms, your diagnosis, or a second opinion.